Trading since 2003 by supplying its core optoelectronic technology and expertise to other early stage biomedical device companies, and building its product base of non-invasive blood perfusion assessment devices.

Board of Directors

Alan Edwards, Chairman
Alan is an experienced executive with an extensive Medical Device Industry background. He is ex CEO of Credent Vascular Technologies Ltd and previously Executive Vice President and Board member at Cardiotech Int Inc (CTE:AMEX). Presently he is on the Board of spin-outs from Oxford University and Imperial College London. He is a member of the European Society for Vascular Surgery and The Vascular Access Society and is an advisor to two Venture Capital funds.

Jody Brown, BA ACA MBA, Chief Executive
Jody is a Chartered Accountant (KPMG) and Executive MBA (London Business School). After 5 years at Lee Cooper (jeanswear manufacturing, distribution and licensing to over 70 countries) as the Group Financial Controller, she left after the trade sale of Lee Cooper. She was a key member of the team of 3 driving and successfully concluding the sale process.

Vincent Crabtree, BEng PhD MIEE, Technical Director
Vincent received his PhD optical vascular assessment at Loughborough University 2003 and BEng (Hons) Electronics at the University of Bradford, 1997. He won the Gatsby Award for Innovation in 2002. He is an experienced hardware engineer with previous experience in commercialising opto-electronic health technology.
 

Clinical and Scientific Advisory Board

Professor George Hamilton MD MB ChB Dip.obs RCOG FRCS
Professor of Vascular Surgery, Consultant Vascular Surgeon, Royal Free Hampstead NHS Trust London. President of Vascular Society of Great Britain and Ireland, Surgeon to the Royal Household.

Professor Shervanthi Homer-Vanniasinkam IBSc MBBS GMC FRCS MD
Professor of Translational Vascular Medicine, University of Bradford. Consultant Vascular Surgeon, Leeds Vascular Institute, The General Infirmary at Leeds. Director, Centre for Atherothrombosis Research, University of Bradford. Clinical Sub-Dean, Medical School, University of Leeds.

Professor Kamlesh Khunti MBChB MD DCH DRCOG MRCGP FRCGP 
Principal in General Practice, Winstanley Health Centre, Leicester. Clinical Senior Lecturer, Department of Health Sciences, Division of General Practice and Primary Health Care, University of Leicester. Collaborator on MRC Cooperative on the development and evaluation of innovative strategies for the prevention of chronic diseases in Primary Care and RCGP representative for the Quality and Outcomes Framework Review Panel for cardiovascular disease.

Professor Melanie Davies MBChB MRCP MD FRCP
Professor of Diabetes Medicine, University of Leicester. Consultant Physician, University Hospitals of Leicester NHS Trust. Principal Investigator for two large population based screening studies which are directly informing the National Screening Committee's proposal for screening for Type 2 Diabetes Mellitus. National Clinical Lead for the DESMOND Education and Self Management Programme, the only nationally recommended programme for Type 2 Diabetes Mellitus and is subject to a national roll-out.

Professor Stephen Greenwald BA PhD
Professor of Cardiovascular Mechanics, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry. Member of Interdisciplinary Research Centre in Biomedical Materials, Queen Mary, University of London. Advanced Research in Cardiovascular pathophysiology, mechanical factors in the genesis of arterial diseases, wave propagation in arteries, non-invasive measurement techniques, histomorphometry.

Henry Connor BSc AMIChemE ARIC AChIArb Licensing & Legal Advisor
With 35 years experience at Johnson Matthey PLC as the Group Licensing Controller with world-wide responsibility for all licenses and all other agreements involving intellectual property. Long and successful experience in formulating and implementing R&D strategies (within the Johnson Matthey Group and in collaboration with other major companies), patent filing and prosecution strategies, the development and exploitation of new technologies.